USA |NASDAQ |USD
| Report Date | Period Ending | EPS Forecast | Last Quarter's EPS | Last Year's EPS |
|---|---|---|---|---|
| Nov 8, 2021 | Sep 2021 | $-0.70 | $-0.65 | $-1.05 |
| Report Date | Period Ending | Revenue Forecast | Last Quarter’s Revenue | Last Year’s Revenue |
|---|---|---|---|---|
| Nov 8, 2021 | Sep 2021 | $2.58M | $2.07M | $1.78M |
Htg Molecular Diagnostics, Inc's next earnings date is Monday, Nov 8, 2021 for the fiscal quarter ending Sep 2021.
| Period End | # of Analysts | EPS Forecast | Low EPS Forecast | High EPS Forecast |
|---|---|---|---|---|
| Dec 2021 | 3 | $-0.57 | $-0.78 | $-0.41 |
| Period End | # of Analysts | EPS Forecast | Low EPS Forecast | High EPS Forecast |
|---|---|---|---|---|
| Dec 2021 | 3 | $-2.54 | $-2.75 | $-2.25 |
| Dec 2022 | 4 | $-2.00 | $-2.54 | $-1.68 |
| Period End | Up/Down 1M | 1M Trend | 2M Trend | 3M Trend |
|---|---|---|---|---|
| Dec 2021 | 0 / 0 | $-0.57 | $-0.61 | $-0.61 |
| Period End | Up/Down 1M | 1M Trend | 2M Trend | 3M Trend |
|---|---|---|---|---|
| Dec 2021 | 0 / 0 | $-2.54 | $-2.85 | $-2.92 |
| Dec 2022 | 0 / 0 | $-2.00 | $-2.31 | $-2.33 |
| Period End | # of Analysts | Revenue Forecast | Low Revenue Forecast | High Revenue Forecast |
|---|---|---|---|---|
| Dec 2021 | 3 | $2.90M | $2.70M | $3.01M |
| Period End | # of Analysts | EPS Forecast | Low EPS Forecast | High EPS Forecast |
|---|---|---|---|---|
| Dec 2021 | 3 | $8.99M | $8.50M | $9.50M |
| Dec 2022 | 4 | $17.21M | $13.50M | $22.00M |
| Report Date | Period Ending | Forecast EPS | Actual EPS | Surprise |
|---|---|---|---|---|
| Nov 8, 2021 | Sep 2021 | $-0.70 | - | - |
| Aug 12, 2021 | Jun 2021 | $-0.77 | $-0.65 | 15.23% |
| May 13, 2021 | Mar 2021 | $-0.98 | $-0.80 | 18.64% |
| Mar 25, 2021 | Dec 2020 | $-1.12 | $-0.91 | 18.51% |
| Nov 10, 2020 | Sep 2020 | $-1.05 | $-1.05 | - |
| Aug 11, 2020 | Jun 2020 | $-1.25 | $-1.18 | 5.32% |
| May 13, 2020 | Mar 2020 | $-1.05 | $-1.20 | -14.29% |
| Mar 25, 2020 | Dec 2019 | $-1.45 | $-0.15 | 89.66% |
| Nov 12, 2019 | Sep 2019 | $-2.48 | $-2.25 | 9.09% |
| Aug 6, 2019 | Jun 2019 | $-2.29 | $-2.55 | -11.48% |
| May 9, 2019 | Mar 2019 | $-2.93 | $-2.85 | 2.56% |
| Mar 7, 2019 | Dec 2018 | $-2.66 | $-1.05 | 60.56% |
| Nov 8, 2018 | Sep 2018 | $-2.85 | $-2.55 | 10.53% |
| Aug 7, 2018 | Jun 2018 | $-3.00 | $-2.10 | 30.00% |
| May 10, 2018 | Mar 2018 | $-3.83 | $-3.20 | 16.27% |
| Mar 22, 2018 | Dec 2017 | $-4.58 | $-2.25 | 50.82% |
| Nov 7, 2017 | Sep 2017 | $-7.80 | $-6.90 | 11.54% |
| Aug 8, 2017 | Jun 2017 | $-8.63 | $-9.00 | -4.35% |
| May 15, 2017 | Mar 2017 | $-10.50 | $-10.95 | -4.29% |
| Mar 23, 2017 | Dec 2016 | $-11.40 | $-11.40 | - |
| Nov 14, 2016 | Sep 2016 | $-12.68 | $-13.80 | -8.88% |
| Aug 9, 2016 | Jun 2016 | $-14.25 | $-14.70 | -3.16% |
| May 12, 2016 | Mar 2016 | $-12.30 | $-15.30 | -24.39% |
| Mar 25, 2016 | Dec 2015 | $-11.93 | $-7.05 | 40.88% |
| Nov 12, 2015 | Sep 2015 | $-0.85 | $-0.76 | 10.59% |
| Aug 6, 2015 | Jun 2015 | $-0.70 | $-1.73 | -147.14% |
| May 6, 2015 | Mar 2015 | - | $-0.73 | - |
| Report Date | Period Ending | Forecast EPS | Actual EPS | Surprise |
|---|---|---|---|---|
| Mar 25, 2021 | Dec 2020 | $-4.80 | $-4.34 | - |
| Mar 25, 2020 | Dec 2019 | $-0.55 | $-7.80 | - |
| Mar 7, 2019 | Dec 2018 | $-0.70 | $-8.90 | - |
| Mar 22, 2018 | Dec 2017 | $-2.03 | $-29.10 | - |
| Mar 23, 2017 | Dec 2016 | - | $-55.20 | - |
| Mar 25, 2016 | Dec 2015 | - | $-10.27 | - |
| Report Date | Period Ending | Forecast Revenue | Actual Revenue | Surprise |
|---|---|---|---|---|
| Nov 8, 2021 | Sep 2021 | $2.58M | - | - |
| Aug 12, 2021 | Jun 2021 | $2.07M | $2.07M | 1.00% |
| May 13, 2021 | Mar 2021 | $1.69M | $1.44M | 0.85% |
| Mar 25, 2021 | Dec 2020 | $2.32M | $2.58M | 1.11% |
| Nov 10, 2020 | Sep 2020 | $2.23M | $1.78M | 0.80% |
| Aug 11, 2020 | Jun 2020 | $1.79M | $1.96M | 1.10% |
| May 13, 2020 | Mar 2020 | $3.04M | $2.23M | 0.73% |
| Mar 25, 2020 | Dec 2019 | $4.85M | $4.80M | 0.99% |
| Nov 12, 2019 | Sep 2019 | $5.47M | $5.40M | 0.99% |
| Aug 6, 2019 | Jun 2019 | $5.56M | $5.80M | 1.04% |
| May 9, 2019 | Mar 2019 | $2.73M | $3.20M | 1.17% |
| Mar 7, 2019 | Dec 2018 | $8.16M | $7.73M | 0.95% |
| Nov 8, 2018 | Sep 2018 | $5.11M | $4.71M | 0.92% |
| Aug 7, 2018 | Jun 2018 | $5.29M | $4.91M | 0.93% |
| May 10, 2018 | Mar 2018 | $4.97M | $4.16M | 0.84% |
| Mar 22, 2018 | Dec 2017 | $6.98M | $7.90M | 1.13% |
| Nov 7, 2017 | Sep 2017 | - | $3.72M | - |
| Aug 8, 2017 | Jun 2017 | - | $1.76M | - |
| May 15, 2017 | Mar 2017 | - | $1.37M | - |
| Mar 23, 2017 | Dec 2016 | - | $1.46M | - |
| Nov 14, 2016 | Sep 2016 | - | $913.90K | - |
| Aug 9, 2016 | Jun 2016 | - | $1.90M | - |
| May 12, 2016 | Mar 2016 | - | $865.23K | - |
| Mar 25, 2016 | Dec 2015 | - | $1.22M | - |
| Nov 12, 2015 | Sep 2015 | - | $1.01M | - |
| Aug 6, 2015 | Jun 2015 | - | $790.55K | - |
| May 6, 2015 | Mar 2015 | - | $1.02M | - |
| Report Date | Period Ending | Forecast Revenue | Actual Revenue | Surprise |
|---|---|---|---|---|
| Mar 25, 2021 | Dec 2020 | $8.25M | $8.55M | 3.62% |
| Mar 25, 2020 | Dec 2019 | $19.25M | $19.20M | -0.24% |
| Mar 7, 2019 | Dec 2018 | $21.96M | $21.50M | -2.08% |
| Mar 22, 2018 | Dec 2017 | $13.80M | $14.76M | 6.95% |
| Mar 23, 2017 | Dec 2016 | - | $5.13M | - |
| Mar 25, 2016 | Dec 2015 | - | $4.04M | - |
HTGM's next earnings date is Monday, Nov 8, 2021 for the fiscal quarter ending Sep 30, 2021.
According to 3 analysts, the average EPS estimation for Htg Molecular Diagnostics, Inc's next quarterly earnings is $-0.70, with a low EPS estimation of $-0.78, and a high estimation of $-0.56.
Over the last 1 month, EPS estimates have seen 0 upward revisions and 0 downward. The EPS 1 month trend is $-0.70, the last 2 month trend is $-0.74, and the 3 month trend is $-0.75.
Based on 3 analysts, the average revenue estimation is $2.58M, with a low revenue estimation of $2.30M, and a high estimation of $3.00M.
Htg Molecular Diagnostics, Inc's previous earnings date was Aug 12, 2021 for its fiscal quarter ended Jun 30, 2021.
HTGM's earnings per share (EPS) was $-0.65, beating the consensus analysts forecast of $-0.77 by 15.23%.
The EPS was higher than the previous fiscal quarter (Mar 2021) by -18.68%, and higher than the same period a year before (Jun 2020) by -45.03%.
Revenues were $2.07M, better than the forecast of $2.07M by 0.01%, up by 44.53% from the previous quarter , and up by 5.65% from the same period last year.
The company reported a net income of $-2.61M.Free cash flow for the quarter was $-4.69M , compared to $-4.45M last quarter and $-4.75M a year before.
HTGM ended the quarter with $10.89M in total debt, a decrease of -8.81% compared to the previous quarter, and a decrease of -2.71% compared to the same quarter a year before.
Htg Molecular Diagnostics, Inc's previous annual earnings date was Mar 25, 2021 for its fiscal year ended Dec 31, 2020.
HTGM's earnings per share (EPS) was $-4.34, beating the consensus analysts forecast of $-4.80 by -9.51% , and higher than the previous year's EPS (Dec 2019) by -44.31%.
Revenues were $8.55M, better than the forecast of $8.25M by 3.62%, and down by -55.48% from previous year's revenue.
The company reported a net income of $-20.87M.
Htg Molecular Diagnostics, Inc reported a free cash flow of $-16.75M for its fiscal year, compared to $-17.80M a year ago.
The company ended the fiscal year with $12.28M in total debt, an increase of 15.61% compared to the previous year.
Get a weekly snapshot of one new investment idea from stock exchanges worldwide.